Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Abouzaid
PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance Among Patients With Multiple Sclerosis in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R2 ) VERSUS R PLUS PLACEBO
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Real-World Cost of Treatment for Multiple Sclerosis Patients Initiating and Receiving Infused Disease-Modifying Therapies Per Recommended Label in the United States
Journal of Medical Economics
Health Policy
Comparing the Quality of Life Among Patients With Relapsing Remitting Multiple Sclerosis in Iraq Using Different Disease Modifying Therapies
Iraqi Journal of Pharmaceutical Sciences
Toxicology
Analytical Chemistry
Pharmaceutics
Pharmacology
Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
Pnd73 - The Impact of Modelling Subsequent Treatment on Estimates of Cost-Effectiveness: An Analysis of Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Adherence of Multiple Sclerosis Patients to Disease Modifying Treatment and Its Impact on Quality of Life
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd131 - Patient Preferences for Different Modes and Frequency of Administration of Multiple Sclerosis Disease Modifying Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparison of Adherence and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies: A Retrospective Administrative Claims Analysis
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Price Analysis of Multiple Sclerosis Disease-Modifying Therapies Marketed in the US
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Infections in Patients With Multiple Sclerosis: Implications for Disease-Modifying Therapy
Acta Neurologica Scandinavica
Medicine
Neurology